icd 10 code for long term use of depo provera

What are the billing codes for Depo Provera?

Oct 01, 2021 · Z79.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79.3 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.3 - other international versions of ICD-10 Z79.3 may differ.

How to order Depo Provera?

Jan 02, 2016 · There are two codes for injectable contraceptives. Z30.09 is for counseling and advice, this is not the one you would use for the encounter for the injection. S sarame Guest Messages 28 Location Lancaster County Best answers 0 Aug 3, 2015 #4 My apologies I meant Z30.9 or perhaps Z30.8 mitchellde True Blue Messages 13,505 Location Columbia, MO

How to buy Depo Provera?

Oct 01, 2021 · Z30.42 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z30.42 became effective on October 1, 2021. This is the American ICD-10-CM version of Z30.42 - other international versions of ICD-10 Z30.42 may differ.

What is the CPT for Depo?

Oct 01, 2021 · Z79.818 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Lng trm (crnt) use of agnt aff estrog recpt & estrog levels. The 2022 edition of ICD-10-CM …

What is the ICD 10 code for DEPO?

Z30.013Depo-Provera is taken from stock and billable on the claim. How should this be coded? Z30. 013 Encounter for initial prescription of injectable contraceptive (Note: It is also acceptable to code Z30.

What is the ICD 10 code for birth control?

Encounter for contraceptive management, unspecified Z30. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z30. 9 became effective on October 1, 2021.

How do you code the depo shot?

Effective January 1, 2013, injection administration of medroxyprogesterone acetate (Depo-Provera) should be reported using HCPCS code J1050 (Injection, medroxyprogesterone acetate, 1 mg).

What is Z30 42 code?

Encounter for surveillance of injectable contraceptive42: Encounter for surveillance of injectable contraceptive.

What is a Depo injection?

Depo-Provera is a well-known brand name for medroxyprogesterone acetate, a contraceptive injection that contains the hormone progestin. Depo-Provera is given as an injection every three months. Depo-Provera typically suppresses ovulation, keeping your ovaries from releasing an egg.Feb 22, 2022

What is DX Z3009?

icd10 - Z3009: Encounter for other general counseling and advice on contraception.

What is CPT code J1050?

HCPCS code J1050 for Injection, medroxyprogesterone acetate, 1 mg as maintained by CMS falls under Drugs, Administered by Injection .

What is CPT code J1030?

“ HCPCS code J1030 is defined as “Injection, methylprednisolone acetate, 40 mg.”Nov 10, 2016

What is CPT code J1050 used for?

Examples: A medroxyprogesterone acetate injection was given for 150 mg for contraceptive use. The provider would bill J1050-FP for 150 units and use a contraceptive management diagnosis code. A medroxyprogesterone acetate injection was given for 500 mg for non-contraceptive use.Feb 11, 2013

What is the ICD-10 code for injection?

Other complications following infusion, transfusion and therapeutic injection, initial encounter. T80. 89XA is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

What is Encounter for procreative management?

ICD-10 code Z31 for Encounter for procreative management is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .

What is Z30 09?

2022 ICD-10-CM Diagnosis Code Z30. 09: Encounter for other general counseling and advice on contraception.

What is the meaning of "long term"?

Long term (current) use of agents affecting estrogen receptors and estrogen levels. Approximate Synonyms. Long term current use of leuprorelin (lupron) dosed by calendar. Long term current use of leuprorelin (lupron) dosed by psa level. Long term current use of leuprorelin (lupron) dosed by testosterone level.

What is a Z00-Z99?

Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00 -Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:

What is billable code?

Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis. The Center for Medicare & Medicaid Services (CMS) requires medical coders to indicate whether or not a condition was present at the time of admission, in order to properly assign MS-DRG codes.

What is inclusion term?

Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.

Is a diagnosis present at time of inpatient admission?

Diagnosis was present at time of inpatient admission. Yes. N. Diagnosis was not present at time of inpatient admission. No. U. Documentation insufficient to determine if the condition was present at the time of inpatient admission. No.

How can primary care clinicians support well informed choices?

Primary care clinicians can support well-informed choices by providing patients with a concise picture of the risks and benefits of each contraceptive method. Additionally, by encouraging partners to attend these edu-cational sessions, clinicians can facilitate responsibility and healthy communication between both parties. In compliant patients, the condom alone, or simultaneous use of the condom and diaphragm (without the irritant spermicide), deserves consideration as a potential option. All users need to be aware of the availability of the emer-gency contraception pill should any issue arise. In non-compliant patients, lower-risk contraceptive options war-rant consideration as a safer alternative to DMPA.

How to address reproductive health issues in adolescents?

To adequately address reproductive health issues in adolescents and young adults, many factors must be taken into consideration and a combination of approaches explored.64-71 Within the context of adolescent wellness, lifestyle, together with the high rate of pregnancies and newly acquired STIs, must be weighed against the short and long-term risks of hormonal interventions. Therefore, it is imperative to find alternative options to DMPA while improving the proper and consistent use of condoms. Furthermore, racial and socioeconomic disparities in pre-scribing practices must be addressed by ensuring that all young people have equal access to information. To accom-plish these goals, school-aged youth must be better edu-cated and the obstacles to compliance and healthy sexual-ity addressed. Such an approach holds considerable prom-ise given that a large number of educational programs with common characteristics were demonstrated to be effective in influencing the sexual health and contracep-tive practices of young people in various cultures and regions.71

What is the most common contraceptive for teenagers?

Currently, the combination (estrogen and progestin) oral contraceptive pill (OCP) and condom are the most common contraceptive methods used by teenagers.1 In cases where women are at an increased risk of estrogen complications, however, progestin-only hormonal contra-ception is often prescribed as the method of choice. This practice applies to women who are breastfeeding or have an increased risk of forming blood clots as well as those who have experienced complications on estrogen-contain-ing contraceptives.2 One of the progestin-only methods, Depo-Provera (DMPA), was originally approved to allevi-ate endometriosis and certain cancers and is currently most commonly used as a contraceptive.3 More than 2 million women in the United States, including approxi-mately 400 000 adolescents, are using DMPA annually as of 2004.4The benefit of DMPA relates to the fact that it is (1) 99% effective at preventing pregnancy when used proper-ly; (2) requires only one injection every 3 months; and (3) offers extended protection due to the crystallized proges-tin that slowly dissolves into the bloodstream.2,3,5 According to James Trussell in his chapter “Contraceptive Efficacy” in Contraceptive Technology: Nineteenth Revised Edition, “The typical failure rate of DMPA is 0.3 per 100 woman-years, which is comparable with that of implantable con-traceptives, copper intrauterine devices (IUDs), and surgi-cal sterilization.”6 Although the condom is the only meth-od that offers protection from transmission of sexually transmitted infections (STIs) and is 98% effective when used properly, prescribers tend to rely on hormonal meth-ods that are less dependent on users’ compliance.6

Does DMPA affect BMD?

Although studies indicate that DMPA reduces BMD and increases the likelihood of fractures during usage, the long-term influence of DMPA following discontinuation has not been established. Given that the drug was approved as a contraceptive in 199231 and osteoporosis is predomi-nately a postmenopausal illness, determining a DMPA-associated influence on the development of osteoporosis has proven difficult. Prescribers, however, must consider all potential eventualities. DMPA may undermine the long-term health of individual users and exacerbate the health care burden associated with osteoporosis-related sequelae. Moreover, to assess the risk-to-benefit ratio of DMPA adequately, it is imperative to understand the long-term implications of osteoporosis fully.

Is DMPA reversible?

Although the FDA’s warning had an impact on pre-scription trends, some studies have offered reassurance, indicating that the DMPA-induced bone loss is at least par-tially reversible following the discontinuation of injections.10,14,15,16 Consequently, DMPA remains a common prescription, often used as a contraceptive for sub-Saharan African women as well as young African American and Native American women who are in their formative years prior to reaching peak bone mass.17 Building peak bone mass usually occurs from preadolescence until approxi-mately age 30.18 This prescription trend is socioeconomi-cally driven and reflects a heightened concern for the per-sonal and public health impact of unplanned pregnancies in these populations. Moreover, given the low socioeconomic status of women in these demographics, DMPA tends to be prescribed as a cheaper alternative compared to other con-traceptives.

Is Depo Provera safe for long term?

While Depo-Provera, or depot medroxyprogesterone acetate (DMPA), is highly effective at preventing preg-nancy, mounting evidence suggests that its side effects may have a negative impact on long-term health. Together with mood changes, weight gain, menstrual irregularities, and delayed return to fertility, recent data indicate a correlation between DMPA use and an increased risk of fracture and HIV infection. These results have intensified concern about whether the ben-efits of DMPA outweigh the long-term risks. This paper reviews the health implications of DMPA and recom-mends alternative contraceptive methods that may have more favorable outcomes.